Which has grown faster, AKBA or CAMP?

Neither grew: over the past five years both shrank revenue, with AKBA's decline the smaller — AKBA at a -0.26% CAGR versus CAMP at -57.68%.

Akebia Therapeutics, Inc. (AKBA) vs CAMP4 Therapeutics Corporation (CAMP)

A side-by-side comparison of Akebia Therapeutics, Inc. and CAMP4 Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AKBA

Akebia Therapeutics, Inc.

$238M

$0.89HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT

CAMP

CAMP4 Therapeutics Corporation

$243M

$3.88HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT

Total return — AKBA vs CAMP

growth of $100 · dividends reinvested · last 2y

AKBA -31.0% (-16.9%/yr)CAMP -62.6% (-38.8%/yr)AKBA compounded faster over this window

AKBA CAMP

AKBA vs CAMP: by the numbers

•CAMP is the larger company ($243M vs $238M market cap).
•Both run net losses; AKBA's is the smaller (-13.54% vs -2543.74% net margin).
•Both shrank revenue over the past five years; AKBA's decline was smaller (-0.26% vs -57.68% CAGR).

Metrics side by side

Valuation

Metric	AKBA	CAMP
P/S ratio	1.09	57.75
P/B ratio	9.51	N/A
FCF yield	16.89%	N/A

Profitability

Metric	AKBA	CAMP
Gross margin	79.48%	53.14%
Operating margin	9.95%	-1488.31%
Net margin	-13.54%	-2543.74%
ROE	-118.58%	N/A
ROIC	-7.08%	-69.76%

Growth (annualized)

Metric	AKBA	CAMP
Revenue CAGR (5Y)	-0.26%	-57.68%
Total return CAGR (5Y)	-20.07%	N/A

Frequently asked

Which has grown faster, AKBA or CAMP?: Neither grew: over the past five years both shrank revenue, with AKBA's decline the smaller — AKBA at a -0.26% CAGR versus CAMP at -57.68%.

Go deeper

Full AKBA analysis Full CAMP analysis Interactive comparison tool

Dig into the metrics

Akebia Therapeutics ROE CAMP4 Therapeutics ROE Akebia Therapeutics operating margin CAMP4 Therapeutics operating margin Akebia Therapeutics revenue growth CAMP4 Therapeutics revenue growth Akebia Therapeutics free cash flow CAMP4 Therapeutics free cash flow

Akebia Therapeutics & CAMP4 Therapeutics appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.